Ramirez, Marivic T.
HRN: 16-48-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2022
CEFUROXIME 1.5GM (VIAL)
12/31/2022
01/07/2023
IVT
1.5 Gms
Q 8 Hrs
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes